Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.71 | 1.36 |
NAV | ₹401.79 | ₹200.90 |
Fund Started | 25 Jun 2004 | 07 May 2007 |
Fund Size | ₹11937.34 Cr | ₹84854.73 Cr |
Exit Load | Exit load for units in excess of 10% of the investment, 1% will be charged for redemption within 1 year. | Exit load of 1% if redeemed within 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 4.99% | 9.62% |
3 Year | 24.61% | 26.22% |
5 Year | 23.60% | 29.69% |
1 Year
3 Year
5 Year
Equity | 98.71% | 93.60% |
Cash | 1.30% | 6.40% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Eternal Ltd. | 4.80% |
Max Healthcare Institute Ltd. | 4.07% |
Dixon Technologies (India) Ltd. | 3.85% |
GE Vernova T&D India Ltd | 3.70% |
Jubilant FoodWorks Ltd. | 3.60% |
Ashok Leyland Ltd. | 3.48% |
Kaynes Technology India Ltd. | 3.34% |
Coforge Ltd. | 3.22% |
SBI Cards And Payment Services Ltd. | 3.21% |
Nippon Life India Asset Management Ltd. | 3.20% |
Name | Assets |
|---|---|
Max Financial Services Ltd. | 4.76% |
Balkrishna Industries Ltd. | 3.54% |
Indian Bank | 3.26% |
Fortis Healthcare Ltd. | 3.18% |
AU Small Finance Bank Ltd. | 3.16% |
Coforge Ltd. | 2.93% |
The Federal Bank Ltd. | 2.91% |
Hindustan Petroleum Corporation Ltd. | 2.90% |
Glenmark Pharmaceuticals Ltd. | 2.87% |
Ipca Laboratories Ltd. | 2.80% |
Name | Sonal Gupta | Chirag Setalvad |
Start Date | 28 Mar 2025 | 28 Jun 2014 |
Name
Start Date
Description | The scheme seeks to generate long-term capital growth from an actively managed portfolio of equity and equity related securities of predominantly mid cap companies. | The scheme seeks to provide long-term capital appreciation/income by investing predominantly in Mid-Cap companies. |
Launch Date | 25 Jun 2004 | 07 May 2007 |
Description
Launch Date